Oral Antibiotics vs. No Prep for Colon Resection Surgery
(REaCT-NSQIP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine whether taking oral antibiotics (neomycin and Flagyl) before colon surgery is more effective than no preparation. It seeks to identify which method aids better recovery and reduces complications after surgery. Suitable candidates for this trial are those scheduled for elective colon surgery who do not require special bowel prep, as determined by their surgeon. As a Phase 4 trial, this research explores how an FDA-approved and proven treatment can benefit more patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What is the safety track record for these treatments?
Research has shown that taking oral antibiotics like Neomycin and Flagyl (Metronidazole) before colorectal surgery can be safe for patients. Studies have found that this combination lowers the risk of wound infections and bacterial complications after surgery.
Most people tolerate these antibiotics well. However, like any medication, they can cause side effects. Some individuals might experience mild stomach issues, such as nausea or diarrhea, but serious side effects are rare.
Using these antibiotics before surgery is a common practice, and they have been safely used for many years, demonstrating their reliability in preventing infections in medical settings.12345Why are researchers enthusiastic about this study treatment?
Researchers are excited about the trial comparing oral antibiotics to no preparation for colon resection surgery because it challenges the current standard, which typically involves bowel preparation to reduce infection risk. Neomycin and Flagyl, the oral antibiotics in question, are being tested for their potential to prevent infections when taken the day before surgery, possibly offering a simpler, less invasive alternative to traditional methods. This approach could lead to easier preparation for patients, reducing the discomfort and complications associated with conventional bowel prep routines.
What evidence suggests that this trial's treatments could be effective for preoperative bowel preparation in colorectal surgery?
This trial will compare the use of oral antibiotics with no preparation before colon resection surgery. Studies have shown that taking oral antibiotics such as Neomycin and Flagyl before colon surgery reduces the risk of infections. Research indicates that these antibiotics lower the chances of wound infections and other bacterial issues. Taking these antibiotics the day before surgery can lead to fewer infections at the surgery site. This method appears to prepare the bowel effectively, helping to prevent post-surgery complications. Overall, using antibiotics in this context has been linked to better outcomes in colon surgery.13467
Who Is on the Research Team?
Sameer Apte, MD
Principal Investigator
The Ottawa Hospital
Rebecca Auer, MD
Principal Investigator
Ottawa Hospital Research Institute
Are You a Good Fit for This Trial?
This trial is for adults who need elective, non-emergency colon surgery and don't require mechanical bowel preparation as decided by their surgeon. They must be able to give oral consent. It's not for those with allergies to the antibiotics metronidazole or neomycin, needing emergency surgery, or certain types of rectal resections.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Preparation
Participants receive either no preparation or oral antibiotics (neomycin and flagyl) the day before surgery
Surgery and Immediate Postoperative Care
Participants undergo elective colorectal surgery and receive immediate postoperative care
Follow-up
Participants are monitored for postoperative complications, quality of life, and other outcomes
Extended Follow-up
Participants are monitored for incidence of C. difficile infections and other long-term outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Neomycin and Flagyl
- No Preparation
Neomycin and Flagyl is already approved in United States, European Union, Canada for the following indications:
- Prevention of surgical site infections in colorectal surgery
- Prevention of surgical site infections in colorectal surgery
- Prevention of surgical site infections in colorectal surgery
- Note: Neomycin is not commercially available in oral formulation in Canada.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ottawa Hospital Research Institute
Lead Sponsor